Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools

Demilade A. Adedinsewo; Amy W. Pollak; Sabrina D. Phillips; Taryn L. Smith; Anna Svatikova; Sharonne N. Hayes; Sharon L. Mulvagh; Colleen Norris; Veronique L. Roger; Peter A. Noseworthy; Xiaoxi Yao; Rickey E. Carter

doi:10.1161/CIRCRESAHA.121.319876

Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools

Demilade A. Adedinsewo, Amy W. Pollak, Sabrina D. Phillips, Taryn L. Smith, Anna Svatikova, Sharonne N. Hayes, Sharon L. Mulvagh, Colleen Norris, Veronique L. Roger, Peter A. Noseworthy, Xiaoxi Yao, Rickey E. Carter

Medicine

Producción científica: Contribución a una revista › Artículo › revisión exhaustiva

41 Citas (Scopus)

Resumen

Cardiovascular disease remains the leading cause of death in women. Given accumulating evidence on sex- and gender-based differences in cardiovascular disease development and outcomes, the need for more effective approaches to screening for risk factors and phenotypes in women is ever urgent. Public health surveillance and health care delivery systems now continuously generate massive amounts of data that could be leveraged to enable both screening of cardiovascular risk and implementation of tailored preventive interventions across a woman's life span. However, health care providers, clinical guidelines committees, and health policy experts are not yet sufficiently equipped to optimize the collection of data on women, use or interpret these data, or develop approaches to targeting interventions. Therefore, we provide a broad overview of the key opportunities for cardiovascular screening in women while highlighting the potential applications of artificial intelligence along with digital technologies and tools.

Idioma original	English
Páginas (desde-hasta)	673-690
Número de páginas	18
Publicación	Circulation Research
Volumen	130
N.º	4
DOI	https://doi.org/10.1161/CIRCRESAHA.121.319876
Estado	Published - feb. 18 2022

Nota bibliográfica

Funding Information:
D.A. Adedinsewo receives research support from the Mayo Clinic Women’s Health Research Center and the Mayo Clinic Building Interdisciplinary Research Careers in Women’s Health program funded by the National Institutes of Health (grant No. K12 HD065987). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.

Publisher Copyright:
© 2022 Lippincott Williams and Wilkins. All rights reserved.

ASJC Scopus Subject Areas

Physiology
Cardiology and Cardiovascular Medicine

PubMed: MeSH publication types

Journal Article
Research Support, N.I.H., Extramural
Review

ODS de las Naciones Unidas

Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

Acceder al documento

10.1161/CIRCRESAHA.121.319876

Otros archivos y enlaces

Citar esto

@article{8fd50ed687e9413f87904f3abff0b57c,

title = "Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools",

abstract = "Cardiovascular disease remains the leading cause of death in women. Given accumulating evidence on sex- and gender-based differences in cardiovascular disease development and outcomes, the need for more effective approaches to screening for risk factors and phenotypes in women is ever urgent. Public health surveillance and health care delivery systems now continuously generate massive amounts of data that could be leveraged to enable both screening of cardiovascular risk and implementation of tailored preventive interventions across a woman's life span. However, health care providers, clinical guidelines committees, and health policy experts are not yet sufficiently equipped to optimize the collection of data on women, use or interpret these data, or develop approaches to targeting interventions. Therefore, we provide a broad overview of the key opportunities for cardiovascular screening in women while highlighting the potential applications of artificial intelligence along with digital technologies and tools.",

author = "Adedinsewo, {Demilade A.} and Pollak, {Amy W.} and Phillips, {Sabrina D.} and Smith, {Taryn L.} and Anna Svatikova and Hayes, {Sharonne N.} and Mulvagh, {Sharon L.} and Colleen Norris and Roger, {Veronique L.} and Noseworthy, {Peter A.} and Xiaoxi Yao and Carter, {Rickey E.}",

note = "Funding Information: D.A. Adedinsewo receives research support from the Mayo Clinic Women{\textquoteright}s Health Research Center and the Mayo Clinic Building Interdisciplinary Research Careers in Women{\textquoteright}s Health program funded by the National Institutes of Health (grant No. K12 HD065987). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: {\textcopyright} 2022 Lippincott Williams and Wilkins. All rights reserved.",

year = "2022",

month = feb,

day = "18",

doi = "10.1161/CIRCRESAHA.121.319876",

language = "English",

volume = "130",

pages = "673--690",

journal = "Circulation Research",

issn = "0009-7330",

publisher = "Lippincott Williams and Wilkins",

number = "4",

}

TY - JOUR

T1 - Cardiovascular Disease Screening in Women

T2 - Leveraging Artificial Intelligence and Digital Tools

AU - Adedinsewo, Demilade A.

AU - Pollak, Amy W.

AU - Phillips, Sabrina D.

AU - Smith, Taryn L.

AU - Svatikova, Anna

AU - Hayes, Sharonne N.

AU - Mulvagh, Sharon L.

AU - Norris, Colleen

AU - Roger, Veronique L.

AU - Noseworthy, Peter A.

AU - Yao, Xiaoxi

AU - Carter, Rickey E.

N1 - Funding Information: D.A. Adedinsewo receives research support from the Mayo Clinic Women’s Health Research Center and the Mayo Clinic Building Interdisciplinary Research Careers in Women’s Health program funded by the National Institutes of Health (grant No. K12 HD065987). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. Publisher Copyright: © 2022 Lippincott Williams and Wilkins. All rights reserved.

PY - 2022/2/18

Y1 - 2022/2/18

N2 - Cardiovascular disease remains the leading cause of death in women. Given accumulating evidence on sex- and gender-based differences in cardiovascular disease development and outcomes, the need for more effective approaches to screening for risk factors and phenotypes in women is ever urgent. Public health surveillance and health care delivery systems now continuously generate massive amounts of data that could be leveraged to enable both screening of cardiovascular risk and implementation of tailored preventive interventions across a woman's life span. However, health care providers, clinical guidelines committees, and health policy experts are not yet sufficiently equipped to optimize the collection of data on women, use or interpret these data, or develop approaches to targeting interventions. Therefore, we provide a broad overview of the key opportunities for cardiovascular screening in women while highlighting the potential applications of artificial intelligence along with digital technologies and tools.

AB - Cardiovascular disease remains the leading cause of death in women. Given accumulating evidence on sex- and gender-based differences in cardiovascular disease development and outcomes, the need for more effective approaches to screening for risk factors and phenotypes in women is ever urgent. Public health surveillance and health care delivery systems now continuously generate massive amounts of data that could be leveraged to enable both screening of cardiovascular risk and implementation of tailored preventive interventions across a woman's life span. However, health care providers, clinical guidelines committees, and health policy experts are not yet sufficiently equipped to optimize the collection of data on women, use or interpret these data, or develop approaches to targeting interventions. Therefore, we provide a broad overview of the key opportunities for cardiovascular screening in women while highlighting the potential applications of artificial intelligence along with digital technologies and tools.

UR - http://www.scopus.com/inward/record.url?scp=85124778612&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85124778612&partnerID=8YFLogxK

U2 - 10.1161/CIRCRESAHA.121.319876

DO - 10.1161/CIRCRESAHA.121.319876

M3 - Article

C2 - 35175849

AN - SCOPUS:85124778612

SN - 0009-7330

VL - 130

SP - 673

EP - 690

JO - Circulation Research

JF - Circulation Research

IS - 4

ER -

Cardiovascular Disease Screening in Women: Leveraging Artificial Intelligence and Digital Tools

Resumen

Nota bibliográfica

ASJC Scopus Subject Areas

PubMed: MeSH publication types

ODS de las Naciones Unidas

Acceder al documento

Otros archivos y enlaces

Huella

Citar esto